Novo Nordisk Secures UK Approval for First Wegovy Weight-Loss Pill
BAGSVÆRD, Denmark, June 11, 2026 Novo Nordisk announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has...
Pharmaceutical Innovation
Advertisement
Simcere and Stanford Partner on Novel IPF Therapy Research
HONG KONG and STANFORD, Calif., June 12, 2026 Simcere Pharmaceutical Group Limited has entered into a strategic research collaboration...
Novartis Advances First Targeted Therapy for Chronic Inducible Urticaria
BASEL, Switzerland, June 12, 2026 Novartis announced new Phase III data at the European Academy of Allergy and Clinical...
XtalPi Advances AI-Powered Drug Discovery Through $400M GPCR Collaboration
BOSTON and SHENZHEN, China, June 10, 2026 XtalPi, a global leader in AI and robotics-driven drug discovery, has announced...
RedHill’s Opaganib Gains FDA Rare Pediatric Disease Status
RALEIGH, North Carolina, USA & TEL AVIV, Israel – June 9, 2026 RedHill Biopharma has received a significant regulatory...
Advertisements
Novo Nordisk Launches Wegovy Pill in UAE Market
BAGSVÆRD, Denmark, June 3, 2026 Novo Nordisk has announced the launch of Wegovy® pill (semaglutide tablets) in the United...
Alnylam and Inceptive Forge $2B AI-RNAi Discovery Alliance
CAMBRIDGE, Massachusetts, USA & PALO ALTO, California, USA, June 3, 2026 Alnylam Pharmaceuticals and Inceptive Nucleics have announced a...
Lupin and Natco Win U.S. FDA Approval for Eribulin Injection
MUMBAI, India & NAPLES, Florida, USA, June 3, 2026 Lupin Limited and its alliance partner Natco Pharma have announced...
AbbVie Secures EU Approval for AQUIPTA as Acute Migraine Treatment
NORTH CHICAGO, Ill., June 2, 2026 AbbVie has announced that the European Commission (EC) has approved AQUIPTA® (atogepant) for...
Johnson & Johnson Wins FDA Label Expansion for TREMFYA
HORSHAM, Pennsylvania, May 28, 2026 Johnson & Johnson has secured a major regulatory milestone after the U.S. Food and...
Advertisement
